289 related articles for article (PubMed ID: 3276283)
1. Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment.
Zohar J; Insel TR; Zohar-Kadouch RC; Hill JL; Murphy DL
Arch Gen Psychiatry; 1988 Feb; 45(2):167-72. PubMed ID: 3276283
[TBL] [Abstract][Full Text] [Related]
2. Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action.
Benkelfat C; Murphy DL; Zohar J; Hill JL; Grover G; Insel TR
Arch Gen Psychiatry; 1989 Jan; 46(1):23-8. PubMed ID: 2910220
[TBL] [Abstract][Full Text] [Related]
3. Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls.
Zohar J; Mueller EA; Insel TR; Zohar-Kadouch RC; Murphy DL
Arch Gen Psychiatry; 1987 Nov; 44(11):946-51. PubMed ID: 3675134
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.
Hollander E; DeCaria C; Gully R; Nitescu A; Suckow RF; Gorman JM; Klein DF; Liebowitz MR
Psychiatry Res; 1991 Jan; 36(1):1-17. PubMed ID: 2017519
[TBL] [Abstract][Full Text] [Related]
5. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
Murphy DL; Zohar J; Benkelfat C; Pato MT; Pigott TA; Insel TR
Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
[TBL] [Abstract][Full Text] [Related]
6. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
Hanna GL; McCracken JT; Cantwell DP
J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):173-8. PubMed ID: 2016218
[TBL] [Abstract][Full Text] [Related]
7. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
Zohar J; Insel TR
Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
[TBL] [Abstract][Full Text] [Related]
8. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR
Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Jenike MA; Hyman S; Baer L; Holland A; Minichiello WE; Buttolph L; Summergrad P; Seymour R; Ricciardi J
Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
[TBL] [Abstract][Full Text] [Related]
10. OCD: where the serotonin selectivity story begins.
Pigott TA
J Clin Psychiatry; 1996; 57 Suppl 6():11-20. PubMed ID: 8647793
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of obsessive-compulsive disorder.
Klein DF
Encephale; 1990; 16 Spec No():331-4. PubMed ID: 2209491
[TBL] [Abstract][Full Text] [Related]
12. Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.
Bastani B; Nash JF; Meltzer HY
Arch Gen Psychiatry; 1990 Sep; 47(9):833-9. PubMed ID: 2203327
[TBL] [Abstract][Full Text] [Related]
13. Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder.
Flament MF; Rapoport JL; Murphy DL; Berg CJ; Lake CR
Arch Gen Psychiatry; 1987 Mar; 44(3):219-25. PubMed ID: 3548637
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of obsessive-compulsive disorder.
Jermain DM; Crismon ML
Pharmacotherapy; 1990; 10(3):175-98. PubMed ID: 2196535
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
Piccinelli M; Pini S; Bellantuono C; Wilkinson G
Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
[TBL] [Abstract][Full Text] [Related]
16. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
Hewlett WA; Vinogradov S; Agras WS
J Clin Psychopharmacol; 1992 Dec; 12(6):420-30. PubMed ID: 1474179
[TBL] [Abstract][Full Text] [Related]
17. Obsessive-compulsive disorder and serotonin: is there a connection?
Insel TR; Mueller EA; Alterman I; Linnoila M; Murphy DL
Biol Psychiatry; 1985 Nov; 20(11):1174-88. PubMed ID: 2413912
[TBL] [Abstract][Full Text] [Related]
18. Tricyclic response in obsessive compulsive disorder.
Insel TR; Mueller EA; Gillin JC; Siever LJ; Murphy DL
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):25-31. PubMed ID: 3991911
[TBL] [Abstract][Full Text] [Related]
19. Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder.
Kreiss DS; Coffman CF; Fiacco NR; Granger JC; Helton BM; Jackson JC; Kim LV; Mistry RS; Mizer TM; Palmer LV; Vacca JA; Winkler SS; Zimmer BA
Pharmacol Biochem Behav; 2013 Mar; 104():119-24. PubMed ID: 23333679
[TBL] [Abstract][Full Text] [Related]
20. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
Insel TR; Murphy DL; Cohen RM; Alterman I; Kilts C; Linnoila M
Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
